Technical Analysis for XPH - SPDR S&P Pharmaceuticals ETF
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 40.59 | -0.47% | -0.19 |
XPH closed down 0.47 percent on Monday, May 6, 2024, on 55 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Flat | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 200 DMA | Bearish | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Weak + Overbought | Other | 0.00% | |
| Weak, Overbought and Reversal Signs | Reversal | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| 200 DMA Support | Bullish | -0.47% | |
| New Uptrend | Bullish | -0.47% | |
| Stochastic Reached Overbought | Strength | -0.47% | |
| Gapped Up | Strength | -0.47% |
| Alert | Time |
|---|---|
| Possible NR7 | about 8 hours ago |
| 60 Minute Opening Range Breakdown | about 10 hours ago |
| Fell Below 200 DMA | about 12 hours ago |
| Fell Below Previous Day's Low | about 12 hours ago |
| 200 DMA Support | 3 days ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index.
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a replication strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.
Keywords: Exchange Traded Fund ETF Index Fund S&P Top 100 Loan Index Pharmaceuticals Segment
Classification
Keywords: Exchange Traded Fund ETF Index Fund S&P Top 100 Loan Index Pharmaceuticals Segment
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 45.4348 |
| 52 Week Low | 34.3786 |
| Average Volume | 32,828 |
| 200-Day Moving Average | 40.75 |
| 50-Day Moving Average | 41.82 |
| 20-Day Moving Average | 40.08 |
| 10-Day Moving Average | 40.02 |
| Average True Range | 0.57 |
| RSI (14) | 49.49 |
| ADX | 25.02 |
| +DI | 28.62 |
| -DI | 27.35 |
| Chandelier Exit (Long, 3 ATRs) | 40.30 |
| Chandelier Exit (Short, 3 ATRs) | 40.59 |
| Upper Bollinger Bands | 41.68 |
| Lower Bollinger Band | 38.48 |
| Percent B (%b) | 0.66 |
| BandWidth | 8.00 |
| MACD Line | -0.37 |
| MACD Signal Line | -0.61 |
| MACD Histogram | 0.2398 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 40.93 | ||||
| Resistance 3 (R3) | 40.93 | 40.81 | 40.88 | ||
| Resistance 2 (R2) | 40.81 | 40.72 | 40.81 | 40.86 | |
| Resistance 1 (R1) | 40.70 | 40.67 | 40.64 | 40.70 | 40.84 |
| Pivot Point | 40.58 | 40.58 | 40.55 | 40.58 | 40.58 |
| Support 1 (S1) | 40.47 | 40.49 | 40.41 | 40.48 | 40.34 |
| Support 2 (S2) | 40.35 | 40.44 | 40.35 | 40.32 | |
| Support 3 (S3) | 40.24 | 40.35 | 40.30 | ||
| Support 4 (S4) | 40.25 |
